PAVmed (PAVM) Share-based Compensation (2016 - 2026)
PAVmed (PAVM) posted quarterly Share-based Compensation of $232000.0 for Q4 2025, down 68.35% year-over-year from $733000.0 in Q4 2024, and down 38.13% quarter-over-quarter from $375000.0 in Q3 2025.
PAVmed (PAVM) Share-based Compensation (2016 - 2026) Analysis & Trends
PAVmed's Share-based Compensation history runs 10 years deep, the most recent figure standing at $232000.0 for Q4 2025.
- In Q4 2025, Share-based Compensation fell 68.35% year-over-year to $232000.0; the TTM figure through Dec 2025 stood at $1.5 million (down 67.06% YoY), while the FY2025 annual figure was $1.7 million, down 73.53% from the prior year.
- Share-based Compensation for Q4 2025 stood at $232000.0, down from $375000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $5.2 million in Q2 2021, with the low at -$8.9 million in Q4 2022.
- The 5-year median for Share-based Compensation is $989000.0 (2023), against an average of $699052.6.
- Peak annual rise in Share-based Compensation reached 883.55% in 2021, while the deepest fall reached 1015.61% in 2021.
- PAVmed's Share-based Compensation stood at -$5.2 million in 2021, then slumped by 70.86% to -$8.9 million in 2022, then surged by 111.09% to $989000.0 in 2023, then dropped by 25.88% to $733000.0 in 2024, then slumped by 68.35% to $232000.0 in 2025.
- Business Quant data shows PAVM's Share-based Compensation at $232000.0 in Q4 2025, $375000.0 in Q3 2025, and $162000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | 917,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 917,000.00 |
| Jun 30, 2026 | 917,000.00 |
| Dec 31, 2025 | 232,000.00 |
| Dec 31, 2025 | 232,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 162,000.00 |
| Jun 30, 2025 | 162,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 934,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 989,000.00 |
| Dec 31, 2023 | 989,000.00 |
| Sep 30, 2023 | 2.25 Mn |
| Sep 30, 2023 | 2.25 Mn |